Streetbeat News

Stock Prices

SMFG

Sumitomo Mitsui Financial Group (NYSE: SMFG) reported Q1 earnings of $0.36 per share, beating the analyst estimate of $0.33. This represents a 33.33% increase from last year's $0.27 per share. Sales were $16.19 billion, a slight decrease from $16.26 billion YoY.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 10:22 am

LIN

Linde expects Q3 adjusted EPS to be between $3.82 and $3.92, slightly below the estimated $3.95. This represents a growth of 5% to 8% compared to the prior-year quarter, or 6% to 9% when excluding a 1% estimated currency headwind.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 10:16 am

CVX

Chevron (NYSE:CVX) reported Q2 2024 earnings per share (EPS) of $2.55, missing the analyst estimate of $2.93 by 12.97%. However, sales were $51.181 billion, beating the estimate of $50.795 billion by 0.76%. EPS decreased by 17.21% year-over-year, while sales increased by 4.67%.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 10:15 am

NWN

NW Natural Holdings reaffirms its long-term EPS growth rate target of 4% to 6% compounded annually from 2022 through 2027.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 10:14 am

NWN

NW Natural Holdings has reaffirmed its 2024 EPS guidance of $2.20 to $2.40, with an estimated EPS of $2.29.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 10:13 am

PRLB

Protolabs has provided its Q3 2024 outlook, expecting revenue between $117M and $125M, below the consensus of $129.624M. The company also anticipates adjusted EPS between $0.29 and $0.37, compared to the consensus of $0.41.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 10:08 am

FIP

FTAI Infrastructure (NASDAQ:FIP) reported Q2 EPS of $(0.52), missing the $(0.34) estimate by 52.94%. Sales were $84.89M, missing the $96.80M estimate by 12.31%. EPS decreased by 36.84% YoY, while sales increased by 3.73% YoY.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 10:06 am

BTSG

BrightSpring Health (NASDAQ:BTSG) reported Q2 2024 earnings per share (EPS) of $0.10, missing the analyst estimate of $0.17 by 41.18%. However, the company reported sales of $2.730 billion, beating the estimate of $2.613 billion by 4.46%. EPS decreased by 33.33% year-over-year, while sales increased by 25.98%.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 10:06 am

NWN

Northwest Natural Hldg (NYSE:NWN) reported Q2 EPS of $(0.07), beating the $(0.12) estimate but showing a significant decrease from last year's $0.03. Sales were $211.71M, missing the $231.99M estimate and down from $237.86M last year.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 10:04 am

PRLB

Proto Labs (NYSE:PRLB) reported Q2 2024 adjusted EPS of $0.38, beating the estimate of $0.35. However, sales of $125.631M missed the $126.245M estimate. EPS increased by 15.15% YoY, while sales grew by 2.75% YoY.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 10:04 am